Concepedia

Ann Setser

AS

Statistics

Publications

9

Citations

1.1K

H-Index

9

Active since

1994

Affiliations

National Cancer Institute(Current)

Memorial Sloan Kettering Cancer Center

National Institutes of Health

Northwestern University

University of California, San Francisco

Ann Setser is an author at National Cancer Institute specializing in oncology, toxicity classification, and serious adverse events.

Publications per year

1994–2017

9

Publications

9

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Alice P. Chen, Ann Setser, Milan J. Anadkat et al. · Journal of the American Academy of Dermatology · 2012 · 351 citations

, , +16

Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin

Lee H. Pai, Robert E. Wittes, Ann Setser et al. · Nature Medicine · 1996 · 209 citations

, , +15

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

Mario E. Lacouture, Michael L. Maitland, Siegfried Segaert et al. · Supportive Care in Cancer · 2010 · 151 citations

, , +13

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

Ethan Basch, Stephanie L. Pugh, Amylou C. Dueck et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 119 citations

, , +16

The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials

A. D. Colevas, Ann Setser · Journal of Clinical Oncology · 2004 · 111 citations

, , +15

1–5 of 9